The discovery and optimization of pyrimidinone-containing MCH R1 antagonists.
Donald L Hertzog, Kamal A Al-Barazanji, Eric C Bigham, Michael J Bishop, Christy S Britt, David L Carlton, Joel P Cooper, Alex J Daniels, Dulce M Garrido, Aaron S Goetz, Mary K Grizzle, Yu C Guo, Anthony L Handlon, Diane M Ignar, Ronda O Morgan, Andrew J Peat, Francis X Tavares, Huiqiang Zhou
Index: Bioorg. Med. Chem. Lett. 16(18) , 4723-27, (2006)
Full Text: HTML
Abstract
Optimization of a series of constrained melanin-concentrating hormone receptor 1 (MCH R1) antagonists has provided compounds with potent and selective MCH R1 activity. Details of the optimization process are provided and the use of one of the compounds in an animal model of diet-induced obesity is presented.
Related Compounds
Related Articles:
A short synthesis of quinazolinocarboline alkaloids rutaecarpine, hortiacine, euxylophoricine A and euxylophoricine D from methyl N-(4-chloro-5H-1, 2, 3-dithiazol-5-ylidene) anthranilates. Mohanta PK and Kim K.
[Tetrahedron Lett. 43(22) , 3993-96, (2002)]
Synthesis and Properties of Some New 1, 4-Dihydrothieno [3, 2-e][1, 2, 4] triazepin-5-ones. Sabri SS, et al.
[Z. Naturforsch. B 61(1) , 65, (2006)]
2001-01-08
[Bioorg. Med. Chem. Lett. 11(1) , 9-12, (2001)]